Galderma (GALD): Agrees $1.5bn cash deal for ZO Skin Health, about 4.5 times its yearly sales
Galderma, the Swiss skin-health group behind Cetaphil, said on 14 October 2026 that it will buy ZO Skin Health, a US brand of skincare sold through…
Home/Companies/Galderma (GALD)
Galderma (GALD)
1 take
All Centiview takes on Galderma (ticker GALD): earnings, deals and market news, newest first. Filed under Healthcare; region: Europe. Each take lists its sources. For information only, not advice.